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Almost 40 years ago, Takatsuki et al. recognized the existence
of a peculiar T cell leukemia in Kyoto, Japan that they named
Adult T Leukemia (ATL). They reported a series of 13 patients
in 1976 (Uchiyama et al., 1977). In 1980, the group of Gallo
reported the discovery of a human oncogenic retrovirus that they
named Human T cell Leukemia Virus type 1 (HTLV-1) in cells
obtained from twoUS patients classified asmycosis fungoides and
Sezary syndrome (Poiesz et al., 1980), but who were, in retrospect,
probably suffering from ATL [for an historical perspective see
(Takatsuki, 2005)]. Shortly after, the groups of Hinuma (Miyoshi
et al., 1981) and of Yoshida (Yoshida et al., 1982) uncovered
the presence of HTLV-1 in cells obtained from ATL patients.
In 1985–1986, two groups independently reported that a neu-
rological disease named HTLV-1 Associated Myelopathy/Tropical
Spastic Paraparesis (HAM/TSP) was also caused by HTLV-1
(Gessain et al., 1985; Osame et al., 1986). Since then, other
inflammatory diseases (uveitis, infective dermatitis) have also
been linked to this viral infection. Other members of the HTLV
family (i.e., HTLV-2, HTLV-3, and HTLV-4 have also now been
reported, none of them being clearly associated so far with an
oncogenic process or a neurodegenerative disease (Kalyanaraman
et al., 1982; Calattini et al., 2005; Wolfe et al., 2005).
Almost 10 years ago, ours colleagues Kuan Teh Jeang and
Mitsuaki Yoshida organized a special issue on HTLV infection in
Oncogene. In setting up this issue, we cannot forget the memory
our friend Teh.
We called upon the expertise of different research groups from
Europe, Japan, and USA. However, we regret that the format of
this issue prevented us from soliciting many other colleagues. The
following reviews will deal with many fascinating aspects of viral
cycle, but summarizes also new approaches that should allow a
better integrated research.
A first group of articles provides information about HTLV-
1 epidemiology and associated-pathogenesis. The article from
Gessain and Cassar provides an updated view on HTLV-1 dis-
tribution, based on data obtained from 1.5 billion individuals
originating from endemic areas (Gessain and Cassar, 2012).
Iwanaga et al. focused their review on ATL epidemiology and
show its peculiar characteristic [age at onset, risk factor, provi-
ral load, etc. (Iwanaga et al., 2012)]. Yamano and Sato provide
an interesting perspective on HAM/TSP physiopathology, and
remind us that optimal therapeutic treatments are still lacking
for those patients (Yamano and Sato, 2012). The review by
Kamoi ad Mochizuki summarizes our current knowledge on
HTLV-1 uveitis, which is the most common cause of uveitis
in endemic areas (Kamoi and Mochizuki, 2012). Going deeper
in the pathological mechanisms linked to HTLV-1 infection,
Yamagishi and Watanabe summarize recent data showing that
ATL cells express abnormally low levels of a cellular oncosup-
pressor miRNA and display some epigenetic changes on the
promoter of genes critical for cell cycle (Yamagishi andWatanabe,
2012).
A second group of articles summarizes the interaction between
the virus and the host’s cells. Before causing diseases, HTLV-1
has to enter the cell. However, the mechanisms of HTLV-1 trans-
mission and cell entry have remained elusive for a long period
of time. Pique and Jones have summarized recent insights about
those mechanisms both at the cell level but also between indi-
viduals (Pique and Jones, 2012). HTLV-1 associated diseases are
linked to the fact that HTLV-1 evades both adaptative and innate
immune responses. Kannagi et al. provide us with an exciting
review, which explains us how the virus evades the interferon
response, but also that dysfunction of the CTL response might be
a risk factor for disease development in infected carriers (Kannagi
et al., 2012).
A third group of articles reports data on individual viral pro-
teins that play important roles in the viral cycle and/or in patho-
genesis. Nakano and Watanabe remind us the important role
played by Rex, which uses cellular pathways to export unspliced or
singly spliced viral mRNAs in the cell cytoplasm, therefore allow-
ing expressing of structural proteins (Nakano and Watanabe,
2012). Currer et al., Zhao and Matsuoka focused their attention
on Tax and HBZ, two viral proteins that play important roles in
the control of viral transcription and oncogenesis (Currer et al.,
2012; Zhao and Matsuoka, 2012). Finally, Bai and Nicot provide
an overview on 4 auxiliary viral proteins (p12, p8, p30, and p13),
which are required for establishing a persistent infection in vivo
(Bai and Nicot, 2012).
Finally, Duc Dodon and colleagues remind us that study-
ing HTLV-1 pathogenesis requires animal models (Dodon et al.,
2012). Rabbits, rats, transgenic mice, and monkeys have been
used in the past. However, recent approaches using human-
ized mice might represent an interesting alternative for studying
HTLV-1 associated diseases.
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